Shares of Stratagene gained 9.5 percent to lead all stocks in the BCW Index for the trading week ended Tuesday. The firm's shares have risen 27 percent since hitting a 52-week low on June 27. Stratagene was only one of four companies in the Index to gain ground for the tracking period. Invitrogen and Agilent led the decliners for the week, falling 5.6 percent and 5.3 percent, respectively.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.